MedTech Forum is next week!
Our next MedTech Forum: Australian MedTech Innovation - The Clinical Research Landscape will be held on Thursday 11th May.  Register to learn more about the ongoing reforms in clinical research, its implementation progress, roadblocks and success.

In addition, sponsors, start-up companies and clinical researchers will have an opportunity to discuss and share their invaluable experience from years of conducting medical devices clinical trials in Australia.

Clinical Trials 2017: National Tribute & Awards Ceremony
The Medical Technology Association of Australia (MTAA) is supporting the Clinical Trials 2017: National Tribute & Awards Ceremony on Friday 19th May, 2017.  

The awards are organised by the Australian Clinical Trials Alliance & the National Health and Medical Research Council which pays tribute to Australia's outstanding achievements in clinical trials and celebrates International Clinical Trials Day.

MTAA MedTech 2017 Annual Conference 
The MTAA MedTech 2017 Annual Conference will be held on 1-2 November 2017 at Doltone House, Jones Bay Wharf, Sydney.  The theme for this year is "The Value of Medical Technology to a Healthier Australia"  

Registration for MTAA MedTech 2017 Annual Conference will open soon.

Pictured: Professor Tony Weiss

Interview with Professor Tony Weiss

Professor Weiss is a rare blend of successful Australian academic researcher, innovator and company Scientific Founder of Elastagen Pty Ltd.  He will be speaking at the next MedTech Forum: Australian MedTech Innovation - The Clinical Research Landscape on Thursday 11th May. He was interviewed by Amanda Ogilvie from the Australian Chamber of Commerce & Industry (ACCI) as part of the Biz Better Together initiative.

How did the idea of Elastagen begin?

It began when I realised we needed to have a vehicle to commercialise the innovations coming out of my lab. Universities are fine places to generate new ideas and contribute to society in many ways, but they are not necessarily the best place when it comes to commercialisation.

Elastagen is a Pty Ltd company that focuses on the commercialisation and applications of material discoveries from my lab to benefit people. It’s a healthcare focused company. The specific products revolve around the use of a material, ‘tropoelastin’, which is a protein that’s the building block used to make all biological elastic tissues, such as skin, blood vessels, tendons and ligaments.

Pre-budget Update 

The Federal Budget is next Tuesday night.  For Treasurer, Scott Morrison MP this will be a critical moment for him and the Government more broadly. The delivery and subsequent sales pitch will potentially determine the success or failure of the Turnbull Government.  The MTAA will be in Canberra on Budget night, Tuesday, May 9.

On Budget Day several MTAA staff members will be present at both the Health and Industry stakeholder lock-up, allowing us to understand the detail and learn more directly from Treasury officials.

On Budget Night, we will put out a press release offering commentary on the Budget and highlighting the key announcements. Subsequently further analysis will be undertaken by the MTAA and circulated to members within 24 hours of the Budget.

New Guidelines for evaluation of TAVI & TAVR devices released

The Department of Health has released the Guidelines for the evaluation of Transcatheter Aortic Valve Replacement devices on its website.  These can be found here...

PDF version: PHI 18/17 Guidelines for evaluation of Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacement devices - TAVR (PDF 46 KB)

The new clinical guidelines for the evaluation of Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacement (TAVR) devices are now available on the Department’s website.

Is your career in the best of health?

Earn your Graduate Certificate in Regulatory Science online

Developed by industry experts, the University of Wollongong Graduate Certificate in Regulatory Science is a 12-month, online course that will give you the qualification you need to become a regulatory affairs specialist.  It’s the perfect health-kick for:

• Your career This course is perfect for those who want to broaden their scope for employment and gain the knowledge to advance and future-proof their regulatory affairs career.
• Public health By focusing on the entire product life cycle, this course will equip you with the skills to protect the health of the public, bring new products to market faster, and more efficiently managing regulatory affairs.
• The business Help navigate the complex regulatory environment to improve investment outcomes for your business by learning a quality management system approach to managing regulatory compliance.

Applications are now open. Course starts 24 July.